Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Identification and management of atypical hemolytic uremic syndrome immediately post-heart transplantation.

Vardas PN, Hashmi ZA, Hadi MA.

J Card Surg. 2015 Apr;30(4):373-5. doi: 10.1111/jocs.12520. Epub 2015 Feb 18.

2.

An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.

Sengul Samanci N, Ayer M, Ergen A, Ozturk S.

Transfus Apher Sci. 2015 Jun;52(3):314-6. doi: 10.1016/j.transci.2015.01.006. Epub 2015 Jan 12.

PMID:
25634788
3.

Complement factor H-antibody-associated hemolytic uremic syndrome: pathogenesis, clinical presentation, and treatment.

Hofer J, Giner T, Józsi M.

Semin Thromb Hemost. 2014 Jun;40(4):431-43. doi: 10.1055/s-0034-1375297. Epub 2014 May 5. Review.

PMID:
24799303
4.

Diagnosis of atypical hemolytic uremic syndrome and response to eculizumab therapy.

Nguyen MH, Mathew JJ, Denunzio TM, Carmichael MG.

Hawaii J Med Public Health. 2014 Sep;73(9 Suppl 1):22-4.

5.

Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.

Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Châtelet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Frémeaux-Bacchi V.

Am J Kidney Dis. 2014 Jan;63(1):40-8. doi: 10.1053/j.ajkd.2013.07.011. Epub 2013 Sep 8.

PMID:
24021908
6.

Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.

Kourouklaris A, Ioannou K, Athanasiou I, Panagidou A, Demetriou K, Zavros M.

J Med Case Rep. 2014 Sep 14;8:307. doi: 10.1186/1752-1947-8-307.

7.

Atypical hemolytic-uremic syndrome immediately after heart transplantation.

Kransdorf EP, Kittleson MM, Kobashigawa JA.

J Heart Lung Transplant. 2014 Jun;33(6):664-5. doi: 10.1016/j.healun.2014.02.006. Epub 2014 Feb 12. No abstract available.

PMID:
24630405
8.

Cryptic activity of atypical hemolytic uremic syndrome and eculizumab treatment.

Belingheri M, Possenti I, Tel F, Paglialonga F, Testa S, Salardi S, Ardissino G.

Pediatrics. 2014 Jun;133(6):e1769-71. doi: 10.1542/peds.2013-2921. Epub 2014 May 19.

PMID:
24843058
9.

Innovative therapeutic approach: sequential treatment with plasma exchange and eculizumab in a pregnant woman affected by atypical hemolytic-uremic syndrome.

Mussoni MP, Veneziano FA, Boetti L, Tassi C, Calisesi C, Nucci S, Rigotti A, Panzini I, Ardissino G.

Transfus Apher Sci. 2014 Oct;51(2):134-6. doi: 10.1016/j.transci.2014.08.027. Epub 2014 Sep 16.

PMID:
25294113
10.

Belgian consensus statement on the diagnosis and management of patients with atypical hemolytic uremic syndrome.

Claes KJ, Massart A, Collard L, Weekers L, Goffin E, Pochet JM, Dahan K, Morelle J, Adams B, Broeders N, Stordeur P, Abramowicz D, Bosmans JL, Van Hoeck K, Janssens P, Pipeleers L, Peeters P, Van Laecke S, Levtchenko E, Sprangers B, van den Heuvel L, Godefroid N, Van de Walle J.

Acta Clin Belg. 2018 Feb;73(1):80-89. doi: 10.1080/17843286.2017.1345185. Epub 2017 Oct 23. No abstract available.

PMID:
29058539
11.

Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society.

Sawai T, Nangaku M, Ashida A, Fujimaru R, Hataya H, Hidaka Y, Kaname S, Okada H, Sato W, Yasuda T, Yoshida Y, Fujimura Y, Hattori M, Kagami S; Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society.

Clin Exp Nephrol. 2014 Feb;18(1):4-9. doi: 10.1007/s10157-013-0911-8.

PMID:
24343712
12.

Atypical hemolytic uremic syndrome: An unusual postoperative complication.

Mota S, Filipe C, Almeida AL.

Rev Esp Anestesiol Reanim. 2018 Jun - Jul;65(6):351-355. doi: 10.1016/j.redar.2017.12.014. Epub 2018 Feb 6. English, Spanish.

PMID:
29426622
13.

Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.

Rigothier C, Delmas Y, Roumenina LT, Contin-Bordes C, Lepreux S, Bridoux F, Goujon JM, Bachelet T, Touchard G, Frémeaux-Bacchi V, Combe C.

Am J Kidney Dis. 2015 Aug;66(2):331-6. doi: 10.1053/j.ajkd.2015.03.039. Epub 2015 May 23.

PMID:
26015278
14.

Diagnosis and treatment of atypical hemolytic uremic syndrome.

Broome C.

Clin Adv Hematol Oncol. 2011 Dec;9(12):939-40. No abstract available.

PMID:
22252664
15.

Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome.

Cugno M, Gualtierotti R, Possenti I, Testa S, Tel F, Griffini S, Grovetti E, Tedeschi S, Salardi S, Cresseri D, Messa P, Ardissino G.

J Thromb Haemost. 2014 Sep;12(9):1440-8. doi: 10.1111/jth.12615. Epub 2014 Jul 16.

16.

Use of Eculizumab in Atypical Hemolytic Uremic Syndrome, Complicating Systemic Lupus Erythematosus.

Bermea RS, Sharma N, Cohen K, Liarski VM.

J Clin Rheumatol. 2016 Sep;22(6):320-3. doi: 10.1097/RHU.0000000000000423.

PMID:
27556240
17.

A case of atypical hemolytic uremic syndrome.

Fallahzadeh MA, Fallahzadeh MK, Derakhshan A, Shorafa E, Mojtahedi Y, Geramizadeh B, Fallahzadeh MH.

Iran J Kidney Dis. 2014 Jul;8(4):341-3.

18.

An unusual case of haemolytic uraemic syndrome following endoscopic retrograde cholangiopancreatography rapidly improved with eculizumab.

Taton O, Delhaye M, Stordeur P, Goodship T, Le Moine A, Massart A.

Acta Gastroenterol Belg. 2016 Apr-Jun;79(2):257-61.

PMID:
27382949
19.

[Eculizumab: effectiveness of a shortened dosing schedule in the treatment of atypical haemolytic uremic syndrome of unknown origin].

Beye F, Malbranche C, Tramecon D, Pernot C, Zanetta G, Mousson C, Guignard MH, Lazzarotti A.

Therapie. 2013 Mar-Apr;68(2):119-22. doi: 10.2515/therapie/2013017. Epub 2013 Jun 18. French. No abstract available.

PMID:
23773354
20.

Atypical Hemolytic Uremic Syndrome: Achieving Positive Patient Outcomes With Early Diagnosis and Appropriate Management
.

Sverdlin D, Peters-Watral B.

Clin J Oncol Nurs. 2017 Aug 1;21(4):481-487. doi: 10.1188/17.CJON.481-487. Review.

PMID:
28738049

Supplemental Content

Support Center